US stock · data to 2026-10-20
Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals: $511.10 on 2026-10-20. +14.1% a year since 2013, worst fall -49%. Year-by-year returns, risk profile and what followed its price patterns in the past.
Open the interactive chart and full historyKey numbers
| Last close | $511.10 |
| Return a year since 2013 | +14.1% |
| All-time high | $557.96 (2026-09-03) |
| Below its high | -8.4% |
| Worst fall | -49% (2016-12-22) |
| Yearly volatility | 36% |
| Beta vs its index | 0.88 |
| Risk / reward vs its market | Low risk · High reward |
Returns by year
| Year | Return |
|---|---|
| 2026 | +12.7% |
| 2025 | +12.6% |
| 2024 | -1.0% |
| 2023 | +40.9% |
| 2022 | +31.5% |
| 2021 | -7.1% |
| 2020 | +7.9% |
| 2019 | +32.1% |
| 2018 | +10.6% |
| 2017 | +103.4% |
| 2016 | -41.5% |
| 2015 | +5.9% |
What followed its price patterns in the past
How often VRTX was higher 40 trading days after each pattern, next to an ordinary day. History for learning, not a forecast.
| Pattern | Past cases | Higher after 40 days | On an ordinary day | Median move |
|---|---|---|---|---|
| Up streak | 55 | 49% | 59% | -0.1% |
| New 52-week high | 46 | 50% | 59% | -0.4% |
| Big up day | 36 | 53% | 59% | +1.1% |
| RSI rises above 70 | 35 | 57% | 59% | +1.0% |
| Down streak | 32 | 69% | 59% | +5.3% |
| Big down day | 31 | 58% | 59% | +2.1% |
| Falls below 200-day avg | 31 | 65% | 59% | +2.0% |
| Crosses above 200-day avg | 30 | 53% | 59% | +1.4% |
| Volume spike on an up day | 20 | 65% | 59% | +3.1% |
| Volume spike on a down day | 20 | 55% | 59% | +1.4% |
| Squeeze breakout up | 19 | 63% | 59% | +6.1% |
| Gap up | 17 | 47% | 59% | -2.0% |
ZOSH shows history and calculations for learning. It is not investment advice and does not tell anyone to buy or sell. Data: Yahoo Finance, AMFI, NSE and official sources; it can be late or wrong, so check before acting.